Blijke Kroezen studied chemistry at the university of Groningen. For her Master’s research she worked on the development of novel medicines for malaria and tuberculosis. She particularly enjoyed the multidisciplinary character of the research project and therefore decided in 2013 to pursue a PhD at the Faculty of Pharmaceutical Sciences at the University of Basel.